MPM BIOVENTURES 2018, L.P. sold 86,482 Entrada Therapeutics shares in separate transactions executed from Sep 1 through Sep 3, 2026. For investors, the disclosed post-sale position is 4,144,952 shares, while the reported execution range for those sales was $7.06 to $7.19 per share.

Key Highlights

  • The sales were executed at prices ranging from $7.06 to $7.19 per share.
  • MPM BIOVENTURES 2018, L.P. completed the transactions between Sep 1 and Sep 3, 2026.
  • The insider owned 4,144,952 Entrada Therapeutics shares after the sales.

MPM BIOVENTURES 2018, L.P. sold 86,482 shares of Entrada Therapeutics, Inc (NASDAQ: TRDA). through separate transactions covering Sep 1 through Sep 3, 2026. The reported prices ranged from $7.06 to $7.19 per share, and the filing identifies MPM BIOVENTURES 2018, L.P. as an insider of Entrada Therapeutics, Inc.

Sales Covered Sep 1 Through Sep 3

The transactions were recorded under transaction code S. The filing reports three separate transactions during the period from Sep 1 to Sep 3, 2026. The price range attached to the transactions was $7.06 to $7.19 per share. Following the activity, MPM BIOVENTURES 2018, L.P. owned 4,144,952 shares of Entrada Therapeutics, Inc. The disclosed ownership figure represents its position after the reported sales.